Human papillomavirus infection: Low-risk and high-risk genotypes in women in Catania, Sicily

International Journal of Gynecological Cancer

Volumn 19, Issue 6, 2009, Pages 1094-1098

  Agodi, Antonella ^a   Barchitta, Martina ^a   La Rosa, Nadia ^a   Cipresso, Rosalba ^a   Guarnaccia, Mariella ^a   Caruso, Melania ^b   Castiglione, Maria Grazia ^b   Ettore, Giuseppe ^b   Travali, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Garibaldi Nesima Hospital   (Italy)

Author keywords

Cross sectional study; Human papillomavirus; Multiple genotypes; Prevalence; Risk factors

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; COLPOSCOPY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PATHOGENESIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SCREENING; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SICILY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 70349255653     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a83c9d     Document Type: Article

References (28)

1. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: aworldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
2. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958-964.
3. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer. 2000;83:561-565.
4. Galloway DA. Papillomavirus vaccines in clinical trials. Lancet Infect Dis. 2003;3:469-475.
5. Unckell F, Streeck R, Sapp M. Generation and neutralization of pseudovirions of human papillomaviru type 33. J Virol. 1997; 71:2934-2939.
6. White WI, Wilson SD, Bonnez W, et al. In vitro infection and type-restricted antibody mediated neutralization of authentic human papillomavirus type 16. J Virol. 1998;72:959-964.
7. Da Silva DM, Eiben GL, Fausch SC, et al. Cervical cancer vaccines: emerging concepts and developments. J Cell Physiol. 2001;186:169-182.
8. Carcheri M, Lacitignola G, Riva R, et al. HPV-DNA research and viral genotyping in diagnosis and prevention of uterine cervix carcinoma. Microbiol Med. 2003;18:39-42.
9. Del Prete R, Di Taranto AM, Lipsi MR, et al. Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol. 2008;42:211-214.
10. Ronco G, Ghisetti V, Segnan N, et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005;41:297-305.
11. Capra G, Giovannelli L, Bellavia C, et al. HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Res. 2008;133:195-200.
12. Rassu M, Bertoloni G, Mengoli C, et al. HPV genotype prevalence in cervical specimens with abnormal cytology: a report from north-east Italy. Scand J Infect Dis. 2005;37:476-481.
13. Tornesello ML, Duraturo ML, Botti G, et al. Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol. 2006;78:1663-1672.
14. Gillio-Tos A, De Marco L, Ghisetti V, et al. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J Clin Virol. 2006;36:126-132.
15. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527. (Pubitemid 36159887)
16. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991-998.
17. Antonishyn NA, Horsman GB, Kelln RA, et al. The impact of the distribution of human papillomavirus types and associated high-risk lesions in a colposcopy population for monitoring vaccine efficacy. Arch Pathol Lab Med. 2008;132:54-60.
18. Franceschi S, Rajkumar R, Snijders PJF, et al. Papillomavirus infection in rural women in southern India. Brit J Cancer. 2005;92:601-606. (Pubitemid 40395546)
19. Chen CA, Liu CY, Chou HH, et al. The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study. Int J Gynecol Cancer. 2006;16:1801-1808.
20. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol. 2004;57:68-72.
21. Stevens MP, Tabrizi SN, Quinny MA, et al. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer. 2006;16:1017-1024.
22. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464-474.
23. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412-420.
24. Smith EM, Johnson SR, Ritchie JM, et al. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet. 2004;87:131-137.
25. Castle PE, Schiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005;191:1808-1816.
26. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24:S1/4-S1/15.
27. Syrjänen K. Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix. Eur J Gynaecol Oncol. 2007;28:337-351.
28. Beerens E, Van Renterghem L, Praet M, et al. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology. 2005;16:199-205.